Apoptosis, cell proliferation and modulation of cyclin‐dependent kinase inhibitor p21cip1 in vascular remodelling during vein arterialization in the rat
- 11 May 2009
- journal article
- research article
- Published by Wiley in International Journal of Experimental Pathology
- Vol. 90 (3) , 328-337
Abstract
Summary: Neo‐intima development and atherosclerosis limit long‐term vein graft use for revascularization of ischaemic tissues. Using a rat model, which is technically less challenging than smaller rodents, we provide evidence that the temporal morphological, cellular, and key molecular events during vein arterialization resemble the human vein graft adaptation. Right jugular vein was surgically connected to carotid artery and observed up to 90 days. Morphometry demonstrated gradual thickening of the medial layer and important formation of neo‐intima with deposition of smooth muscle cells (SMC) in the subendothelial layer from day 7 onwards. Transmission electron microscopy showed that SMCs switch from the contractile to synthetic phenotype on day 3 and new elastic lamellae formation occurs from day 7 onwards. Apoptosis markedly increased on day 1, while α‐actin immunostaining for SMC almost disappeared by day 3. On day 7, cell proliferation reached the highest level and cellular density gradually increased until day 90. The relative magnitude of cellular changes was higher in the intima vs. the media layer (100 vs. 2 times respectively). Cyclin‐dependent kinase inhibitors (CDKIs) p27Kip1 and p16INKA remained unchanged, whereas p21Cip1 was gradually downregulated, reaching the lowest levels by day 7 until day 90. Taken together, these data indicate for the first time that p21Cip1 is the main CDKI protein modulated during the arterialization process the rat model of vein arterialization that may be useful to identify and validate new targets and interventions to improve the long‐term patency of vein grafts.Keywords
This publication has 33 references indexed in Scilit:
- Original Research: Local TAT-p27Kip1 Fusion protein inhibits cell proliferation in rat Carotid arteriesTherapeutic Advances in Cardiovascular Disease, 2008
- Tumor Necrosis Factor Receptor-2 Signaling Attenuates Vein Graft Neointima Formation by Promoting Endothelial RecoveryArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Biphasic effect of p21Cip1 on smooth muscle cell proliferation: Role of PI 3-kinase and Skp2-mediated degradationCardiovascular Research, 2006
- Vein Graft Neointimal Hyperplasia Is Exacerbated by Tumor Necrosis Factor Receptor-1 Signaling in Graft-Intrinsic CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Early Adaptive Responses of the Vascular Wall during Venous Arterialization in MiceThe American Journal of Pathology, 2004
- Mediation of Proliferating Cell Nuclear Antigen (PCNA)-dependent DNA Replication through a Conserved p21Cip1-like PCNA-binding Motif Present in the Third Subunit of Human DNA Polymerase δJournal of Biological Chemistry, 2001
- Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.Journal of Clinical Investigation, 1997
- Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.Journal of Clinical Investigation, 1995
- The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNANature, 1994
- Atherosclerosis after Coronary Artery Bypass Surgery: Results of Recent Studies and Recommendations Regarding PreventionCardiology, 1986